Data protection
Thank you for visiting our website and your interest in our services. Data protection is important to us. For information about how we protect and use your data, please refer to the privacy policy and to the website and cookie notice.
Privacy policy
Reichmuth & Co’s privacy policy is based on Swiss data protection law and, if and to the extent applicable to Reichmuth & Co, on the General Data Protection Regulation of the European Union (EU GDPR). The privacy policy contains information on how we process and protect our customers’ personal data.
Website and cookie notice
The website and cookie notice contains information about how Reichmuth & Co protects your data which is collected, processed and used during your visit to this website, including specific information on cookies.
By accessing our website, you consent to our website and cookie notice. If you do not agree with this, you must refrain from accessing the Reichmuth & Co website.
The privacy policy and website and cookie notice may be updated at any time. We therefore recommend that you check them regularly.
If you have any questions about the processing of your personal data, please address them by letter or email to Reichmuth & Co’s data protection officer:
Reichmuth & Co Privatbankiers
Data Protection Officer
Ruetligasse 1
CH-6003 Luzern
+41 41 249 49 49
datenschutz@reichmuthco.ch
Aktuelles
Is the Swiss currency rocket taking off?
Switzerland is sitting on a ticking currency time bomb: the Swiss franc. What has been regarded as a sign of stability and solidity for years could prove highly explosive in the event of a new global economic shock. While the Swiss Confederation shines as a safe haven with one of the lowest debt ratios in the world and a credible monetary stability policy pursued by the SNB, it is precisely this status that threatens to become a challenge.
Swiss pharmaceutical industry facing political headwinds
The pharmaceutical industry is currently high on Donald Trump’s list of priorities. He wants more production and jobs in the US, as well as lower drug prices. As a means of exerting pressure, he is threatening to impose price caps and introduce tariffs on drugs. These goals are, of course, contradictory, which is causing even more uncertainty.
Market commentary on the US trade conflict with Switzerland
The list of new customs measures against Switzerland, published on the night of Swiss National Day on August 1, came as a surprise. The economic impact of the tariffs is significant.